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OBJECTIVE—In white adipose tissue, adipocytes and adipo-
cyte precursor cells are enmeshed in a dense network of type I
collagen ﬁbrils. The fate of this pericellular collagenous web in
diet-induced obesity, however, is unknown. This study seeks to
identify the genetic underpinnings of proteolytic collagen turn-
over and their association with obesity progression in mice and
humans.
RESEARCH DESIGN AND METHODS—The hydrolysis and
degradation of type I collagen at early stages of high-fat diet
feeding was assessed in wild-type or MMP14 (MT1-MMP)-hap-
loinsufﬁcient mice using immunoﬂuorescent staining and scan-
ning electron microscopy. The impact of MMP14-dependent
collagenolysis on adipose tissue function was interrogated by
transcriptome proﬁling with cDNA microarrays. Genetic associ-
ations between MMP14 gene common variants and obesity or
diabetes traits were examined in a Japanese cohort (n  3,653).
RESULTS—In adult mice, type I collagen ﬁbers were cleaved
rapidly in situ during a high-fat diet challenge. By contrast, in
MMP14 haploinsufﬁcient mice, animals placed on a high-fat diet
were unable to remodel fat pad collagen architecture and display
blunted weight gain. Moreover, transcriptional programs linking
type I collagen turnover with adipogenesis or lipogenesis were
disrupted by the associated decrease in collagen turnover. Con-
sistent with a key role played by MMP14 in regulating high-fat
diet–induced metabolic programs, human MMP14 gene polymor-
phisms located in proximity to the enzyme’s catalytic domain
were closely associated with human obesity and diabetes traits.
CONCLUSIONS—Together, these ﬁndings demonstrate that the
MMP14 gene, encoding the dominant pericellular collagenase
operative in vivo, directs obesogenic collagen turnover and is
linked to human obesity traits. Diabetes 59:2484–2494, 2010
O
besity is closely linked to the development of
diabetes and negatively affects life expectancy
(1–3). At early stages of obesity, gene programs
are activated within fat depots that support
tissue expansion, which arises as a combined result of the
hypertrophic growth of adipocytes and the recruitment of
adipocyte precursors to the adipogenic process (4,5).
Within adipose tissues, both adipocytes and adipocyte
precursors are enveloped by a dense network of type I
collagen (6,7). This collagenous web is presumed to pro-
vide adipose tissues with structural integrity and elasticity
necessary to maintain optimal form and function (8).
Matrix metalloproteinase (MMP)14 (MT1-MMP) is a peri-
cellular type I collagenase that is critical for the postnatal
development of the mesenchyme, including adipose tis-
sues (7). Whether the developmental role played by
MMP14 during adipogenesis is relevant to the pathogene-
sis of adult obesity remains unclear. The premature mor-
bidity and mortality observed in MMP14 knockout mice
(7,9) preclude attempts to assess the impact of nutritional
interventions on adult obesity in these animals. Moreover,
it has not been determined whether the diet-induced
expansion of fat mass is functionally linked to the remod-
eling of the type I collagen network.
Here, we demonstrate that the type I collagen architec-
ture of adipose tissues undergoes rapid degradative re-
modeling in response to a high-fat diet challenge in vivo
via a proteolytic process mediated by MMP14 (10). A
reduction in MMP14 dosage not only prevents the diet-
induced cleavage of the type I collagen network in vivo but
also disrupts the regulation of the transcriptional pro-
grams linked to adipogenesis and lipogenesis. Consistent
with insights obtained from analyses of genetically modi-
ﬁed mice, human MMP14 single nucleotide polymor-
phisms (SNPs) are identiﬁed that positively associate with
human obesity and diabetes traits. Taken together, these
data support a new model wherein MMP14 not only
participates in obesity pathogenesis but also serves as a
potential genetic modiﬁer of obesity and diabetes predis-
position in humans.
RESEARCH DESIGN AND METHODS
Mice, diets, and metabolic phenotyping. MMP14
/ mice were kindly
provided by Dr. Motoharu Seiki (University of Tokyo) and maintained in
C57BL/6 background (11). MMP14 haploinsufﬁcient (MMP14
/) and wild-
type (MMP14
/) male mice, aged 12 weeks, were used for all experiments.
Each mouse was housed individually and placed on a high-fat (45% fat) or
control (10% fat) diet (Research Diets) for the indicated periods of time. In
selected studies, mice were individually housed in Oxymax/CLAMS metabolic
chambers (Columbus Instrument) for metabolic studies. After 2 days’ accli-
mation, VO2, food consumption, and x-y ambulation were measured consecu-
tively for 4 days.
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formaldehyde and frozen sections prepared for analysis. MMP-dependent
collagen degradation products were detected with C1-2C antibody (IBEX)
(12). Fibrillar collagens were stained with Sirius red and quantiﬁed with
ImageJ (NIH) (7). Student’s t test (unpaired and two tailed) was used for
statistical analysis.
Collagenolysis in vitro. Primary preadipocytes were isolated from the
inguinal fat pads of 3- to 4-week-old male wild-type and haploinsufﬁcient
(MMP14
/) mice (7). Type I collagen was extracted from rat tails and
conjugated with Oregon Green 488 (Molecular Probe) (13). Preadipocytes
were cultured atop ﬂuoresceinated type I collagen polymers with or without
an adipogenic mix (0.2 mol/l insulin, 0.5 mmol/l 3-isobutyl-1-methylxanthine,
and 0.25 mol/l dexamethsone) (7). Nuclei were stained with DAPI and zones
of collagenolysis identiﬁed with a ﬂuorescent microscope (model no. IX71;
Olympus) using an objective lens 40/NA 0.65 (Olympus) at 25°C.
GeneChip microarray analysis. Total RNA was isolated from adipose
tissues with RNeasy (Qiagen). Gene expression data were obtained by
hybridizing labeled cRNA to Affymetrix Mouse Genome 430 2.0 Array. For
analysis, data were standardized using the robust multiarray average expres-
sion measure (14). The paired t test was two tailed, and P  0.01 was
considered statistically signiﬁcant. Replicated, minimum twofold differences
were adopted as the threshold of differential expression. Gene ontology
analysis was performed using GOstats packages (BioConductor).
Scanning electron microscopy. Scanning electron microscopy was used to
examine the architecture of fat pad–associated collagen. Inguinal fat pads
were ﬁxed with 2% glutaraldehyde/1.5% paraformaldehyde in 0.1 mol/l Na
cacodylate buffer and postﬁxed in 1% osmium tetroxide. Samples were
immersed in liquid N2, fractured to expose the inner mass of adipose tissues,
and imaged with an AMRAY 1910 ﬁeld emission scanning electron
microscope.
Human subjects. Japanese healthy individuals with no obvious medical
conditions (n  3,653) were recruited through random sampling (15). All
subjects gave written informed consent prior to the study, and the study
design (Millennium Genome Project) was approved by the institutional review
board and the ethics committee of the National Cardiovascular Center, Osaka,
Japan.
MMP14 gene SNP study. Genomic DNA samples were collected from
peripheral leukocytes. MMP14 gene variations were detected by TaqMan PCR
(ABI PRISM 7900HT) and veriﬁed in a subset of samples by direct sequencing
(ABI 3700). Haplotype distribution was estimated with an EM algorithm (16).
The association of MMP14 gene haplotypes with age- and sex-adjusted
quantitative traits was tested with the QTLHAPLO program (17) using logistic
regression analysis (18). The genotype-phenotype association with rs2236302
was performed with one-way ANCOVA adjusted for age, history of smoking,
drinking, diabetes, hypertension, and hyperlipidemia.
RESULTS
High-fat diet triggers acute collagenolytic activity in
adipose tissue. To characterize the impact of nutrition-
ally induced obesity on the remodeling of the extracellular
matrix (ECM) in adipose tissues, 3-month-old C57BL/6
mice were placed on either a low-fat (control) or high-fat
diet for 1 week. Subsequently, inguinal fat pads were
isolated and type I collagen architecture was assessed by
Sirius red staining. As expected, adipose tissues recovered
from mice placed on a control diet displayed a web-like
network of interlocking collagen ﬁbrils (Fig. 1A). In
marked contrast, a high-fat diet induced signiﬁcant de-
creases in Sirius red staining consistent with an unexpect-
edly rapid activation of collagenolytic activity (Fig. 1A and
B). Given the dominant role assigned to matrix metallo-
proteinases in type I collagen turnover in vivo (7,9),
adipose tissues prepared from control or high-fat diet–
challenged mice were probed for the generation of colla-
gen cleavage products with a polyclonal antibody that
recognizes type I collagen neoepitopes exposed following
MMP-speciﬁc hydrolysis (12). While control fat pads con-
tained only small amounts of immunoreactive material,
collagen cleavage products increased more than threefold
in the high-fat diet–challenged group (Fig. 1A and C).
Consistent with these results, scanning electron micros-
copy conﬁrmed that the high-fat diet challenge induces a
marked loss in the adipocyte-associated meshwork of
ﬁbrillar collagen (Fig. 1A).
To assess the impact of high-fat diet–initiated ECM
remodeling on the adipose tissue transcriptome, mRNA
was isolated from inguinal fat pads of control or high-fat
diet–challenged mice and analyzed with cDNA microar-
rays. Following 1 week’s feeding of a high-fat diet, a subset
of 113 transcripts was upregulated by twofold or greater
with 34 transcripts suppressed (Fig. 1D). Uniquely up- and
downregulated genes in the inguinal fat pads of wild-type
mice can be found in supplemental Table 1 (available in an
online appendix [http://diabetes.diabetesjournals.org/cgi/
content/full/db10-0073/DC1]). Gene ontology analysis of
upregulated transcripts revealed the enrichment for bio-
logic processes related to collagen catabolism (P  0.004),
collagen ﬁbril organization (P  0.003), and integrin-
mediated signaling (P  0.002), a major transduction
pathway for adipocyte-type I collagen interactions (19,20).
Interestingly, gene programs consistent with acute
changes in lipid biosynthesis (P  0.001), steroid metab-
olism (P  0.003), and biosynthesis (P  0.003) were also
upregulated in tandem with the recruitment of ECM-
remodeling transcripts (Fig. 1E). Taken together, these
data support a model wherein high-fat diet–induced
changes in ECM remodeling are closely linked to the early
transcriptional programs responsible for regulating lipid
and cholesterol biosynthesis—a conclusion corroborated
by recent studies linking a collagen subfamily member to
the regulation of adipose tissue mass (21).
MMP14 mediates high-fat diet–induced collagenoly-
sis in adipose tissues. While a number of secreted MMPs
express type I collagenolytic activity (22), MMP-13,
MMP-8, and MMP-2 expression were not altered following
challenge with a high-fat diet. By contrast, expression
levels of the membrane-anchored collagenase, MMP14,
were increased twofold during the 1-week-long high-fat
diet challenge as assessed by quantitative PCR (relative
mRNA levels: high-fat diet 7.2  0.95 vs. control 3.4  0.10;
n  4). MMP14 is a membrane-tethered matrix metallo-
proteinase that has been identiﬁed as the dominant peri-
cellular collagenase used by mesenchymal cells (7,13,23).
As the collagenolytic activity of isolated mouse preadipo-
cytes is enhanced in the presence of an adipogenic cock-
tail (7), the impact of MMP14 dosage on collagenolytic
activity was ﬁrst assessed in vitro. Under resting condi-
tions, MMP14
/ or MMP14
/ preadipocytes cultured
atop a three-dimensional bed of type I collagen ﬁbrils
degraded the underlying substrate comparably (Fig. 2A
and B). When stimulated with an adipogenic mix, how-
ever, MMP14
/ cells displayed a two-fold increase in
collagenolysis while MMP14
/ cells were unable to up-
regulate their collagen degrading activity (Fig. 2A and B).
Loss of adipogenic collagenolysis in the haploinsufﬁcient
state is consistent with a quantitative requirement for the
full complement of MMP14 protein on the cell surface
(24).
Given these in vitro ﬁndings, the role of MMP14 in
regulating collagen turnover in adipose tissues in situ was
assessed in haploinsufﬁcient mice because MMP14-null
mice fail to thrive from birth and exhibit a marked
decrease in life span (9). MMP14 haploinsufﬁcient mice
were indistinguishable from wild-type littermates, and no
signiﬁcant differences in adipose tissue size or morphology
could be detected between MMP14
/ and MMP14
/
mice (supplemental Fig. 1). Furthermore, gene expression
patterns of key adipogenic factors including peroxisome
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and lipoprotein lipase (25) were similar between the two
groups (supplemental Fig. 1). When, however, MMP14
/
mice were placed on a high-fat diet, only small decreases
in ﬁbrillar collagen content were detected relative to
littermate controls (Fig. 2C and D). Furthermore, signiﬁ-
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FIG. 1. Type I collagen degradation induced by high-fat feeding. A: Type I collagen cleavage induced by a 1-week regimen of high-fat diet feeding.
Fibrillar collagen is detected with Sirius red staining in inguinal fat pads of 3-month-old C57BL/6 mice under a control diet (CD) (top row) or high-fat
diet (HFD) (bottom row) feeding. Type I collagen cleavage products are detected with C1, 2C antibody (cleaved collagen, red). Nuclei are stained with
Hoechst dye (blue). The ﬁbrillar status of type I collagen ﬁbrils encircling adipocyte clusters is disrupted when mice are placed on an HFD (scanning
electron microscopy [SEM]). Disrupted collagen ﬁbers (arrowhead) are found in association with variably sized adipocytes (asterisks). Bar  10 m.
B and C: Quantiﬁcation of Sirius red–positive staining and cleaved collagen in the inguinal fat pads of mice after 1 week of control diet or high-fat
feedings. For each group, images were collected from more than six randomly selected ﬁelds. *P < 0.01; **P < 0.01. D: Genome-wide transcriptome
change induced by a 1-week high-fat diet challenge. While more than 99% of transcripts did not display signiﬁcant changes (x-axis, control diet; y-axis,
high-fat diet), a speciﬁc subset of genes display a signiﬁcant increase in expression. Replicated dataset from two independent experiments. Slopes with
y-intercepts 0, 1, and 1 (log 2 scale) are shown. E: Overrepresented gene ontology (GO) pathways. High-fat diet–dependent transcriptome changes
after a 1-week high-fat diet challenge are categorized following validation in two or more independent experiments. Bar  100 m. *Lipid/cholesterol
biosynthesis pathways; **ECM remodeling pathways. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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FIG. 2. MMP14 gene dosage determines adipogenic collagenolysis in vitro and in vivo. A and B: Collagenolytic potential of MMP14
/ vs. MMP14
/
preadipocytes. Preadipocytes isolated from the inguinal fat pads of wild-type (MMP14
/) and haploinsufﬁcient (MMP14
/) mice were cultured atop
a bed of ﬂuorescent type I collagen (green), and subjacent degradation was monitored by the disappearance of ﬂuorescent signal after a 3-day culture
period in the absence or presence of an adipogenic cocktail. Representative zones of degradation are indicated by arrows. Nuclei stained with DAPI
(blue). Bar  100 m. Collagenolytic activity was quantiﬁed by scanning the total area of degraded collagen. Cells were isolated from a cohort of three
mice for each group (n  3). *P < 0.05. C: MMP14 gene dosage modulates collagenolysis in vivo. High-fat diet–induced collagenolysis is almost
completely blocked by MMP14 haploinsufﬁciency (ﬁbrillar collagen detected with Sirius red staining and cleaved collagen by immunoﬂuorescence)
(red). Bar  100 m. Scanning electron microscopy revealed intact collagen ﬁbers enwrapping adipocytes in MMP14
/, but not MMP14
/, inguinal
fat pads. Bar  100 m. D: Cleaved collagen and ﬁbrillar collagen contents in inguinal fat pads of MMP14
/ and MMP14
/ mice following a 1-week
control diet or high-fat diet challenge. Results are expressed as means  1S D( n  6). *P < 0.01. E: Following a 2-week high-fat diet, the inguinal and
perigonadal fat pads were isolated from MMP14
/ or MMP14
/ mice and tissue weights determined. Results are expressed as means  1S D( n  6).
*P < 0.01. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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high-fat challenge were not observed in MMP14
/ mice,
while the ﬁbrillar collagen architecture (as determined by
scanning electron microscopy) remained unchanged (Fig.
2C). In concert with the diminished ability of MMP14
haploinsufﬁcient mice to remodel fat pad collagen archi-
tecture during high-fat feeding, the MMP14
/ mice were
also unable to expand their adipose mass comparably with
control (Fig. 2E). Whereas the weight of inguinal or
perigonadal adipose tissue of MMP14
/ mice increased
two- to threefold during the 1-week high-fat diet challenge,
the haploinsufﬁcient mice failed to mount a similar in-
crease in adipose tissue mass (Fig. 2E).
Dysregulated transcriptome coordination in MMP14
haploinsufﬁcient mice. To probe the functional impact
of MMP14 in regulating the acute phase gene response to
a high-fat diet, we examined the transcriptome proﬁle of
inguinal fat pads of MMP14 haploinsufﬁcient mice placed
on a high-fat diet for 1 week. In contrast with MMP14-
sufﬁcient mice, the haploinsufﬁcient animals failed to
induce the gene sets enriched for ECM remodeling or lipid
biosynthesis (Fig. 3A and B). Further, as opposed to
wild-type mice, 42 genes were uniquely upregulated and 91
genes downregulated in the heterozygote animals (Fig. 3A,
supplemental Fig. 2, and supplemental Table 2). In these
mice, the high-fat diet challenge led to a paradoxical
deregulation in the gene expression proﬁle of transcripts
involved in a wide range of biological processes, including
glycerol-3-phosphate metabolism, acetyl-CoA biosynthe-
sis, and both humoral immune and acute phase responses
(Fig. 3B). These results indicate that a reduction in
MMP14 gene dosage leads to a disruption in the transcrip-
tional link existing between ECM remodeling and lipid
biosynthesis that coordinates the expansion of adipose
tissue.
To next assess the long-term consequences of MMP14
haploinsufﬁciency on high-fat diet–induced obesity, wild-
type and haploinsufﬁcient mice were placed on a high-fat
diet for 3–6 months. The average percentage of fat mass of
MMP14 haploinsufﬁcient and wild-type mice placed under
a control diet was comparable (mean  SD 5.29  0.58 vs.
5.07  0.7%; n  6). On the high-fat diet, however, whereas
wild-type mice displayed an approximate 20 and 60%
weight gain after 3 and 6 months, respectively, MMP14
/
mice increased in total weight by less than one-half of that
observed in the control (Fig. 3C). As expected, the dra-
matic changes in weight gain that occured in the long-
term, high-fat feeding of MMP14
/ mice was also
reﬂected in the attenuated expansion of tissue mass in
isolated inguinal and perigonadal fat pads (Fig. 3D).
Changes in MMP14 expression did not, however, affect
whole-body energy balance during high-fat feeding be-
cause the respiration rate, daily food intake, and locomo-
tion of wild-type and heterozygous mice were not
signiﬁcantly different (Fig. 3F). These results stress the
role of MMP14 as a proteolytic modiﬁer that acts locally
within adipose tissues without overtly affecting the hypo-
thalamic regulation of metabolism.
Human MMP14 SNPs associate with obesity and dia-
betes traits. Obesity is driven by a complex process that
is coordinated by a host of genetic, epigenetic, and envi-
ronmental factors (26–28). To extend the ﬁndings of the
genotype-phenotype link found in mice, the association of
MMP14 SNP genotypes with human obesity and diabetes
traits was examined. The human MMP14 gene is located at
chromosome 14q11–12, comprising 10 exons and spanning
a 10-kb region that contains 157 known SNPs (NCBI
dbSNP). Using a preliminary group (n  48) randomly
sampled from a Japanese population (15), we assessed the
minor allele frequencies of candidate MMP14 SNPs (Fig.
4A). Initially, 16 SNPs spanning human MMP14 gene (from
rs17211964 at chr14:23,304,272 through rs2236307 at chr14:
23,312,554) were screened to determine their pairwise
linkage disequilibrium coefﬁcients (supplemental Tables 1
and 2). Three SNPs located in exon 5 (rs2236302; allele 2,
C 	 allele 1, G), intron 5 (rs2236304; allele 2, C 	 allele 1,
G), and exon 6 (rs2236307; allele 2, T 	 allele 1, C) were
chosen based on their frequency (	10%), proximity to the
catalytic domain of MMP14, and pairwise linkage disequi-
librium that allow diverse haplotypes in combination. The
minor allele (allele 1) frequency for the three SNPs among
the study population was 11.0, 44.8, or 38.5%, respectively
(Fig. 4A).
Using a study population that included 3,653 individuals
consisting of 1,708 men and 1,945 women, we assessed
MMP14 haplotypes. The analysis of the pairwise linkage
disequilibrium among the three SNPs suggested that they
constitute a block of haplotypes (D
	 0.977). However,
the estimated square of the correlation coefﬁcient (r
2)
among the studied SNPs were sufﬁciently low (Table 1) to
allow for the assembly of at least four major haplotypes
(Fig. 4B). The association of MMP14 haplotypes with
obesity and diabetes traits, i.e., BMI, waist-to-hip ratio,
body fat, A1C, fasting blood glucose and insulin levels,
homeostasis model assessment (HOMA) of insulin resis-
tance and -cell function, was examined in the dominant
or recessive genetic model with multiple logistic regres-
sion analysis (17,18,28). Among the four major haplotypes
of the MMP14 gene (212, 221, 122, and 222), the haplotype
122 (GCT) was found to positively associate with BMI
(P  0.0017) (Fig. 4C) and waist-to-hip ratio (P  0.0079)
(Table 2). Because of the dominant role played by
rs2236302 in deﬁning the link between obesity traits and
MMP14 haplotypes, rs2236302 genotype was used to fur-
ther delineate the link between MMP14 genotype and
quantitative obesity traits. The distribution of C/C, C/G,
and G/G genotypes were 79.7% (n  2,908), 19.1% (n 
695), and 1.2% (n  44) among the study population. Due
to the low frequency of the G/G genotype, the quantitative
association study was performed by comparing between
homozygote C/C and heterozygote C/G genotype groups.
The association with obesity traits was then examined
in a genotype or dominant model with ANCOVA. In the
multivariate analyses of the total population, BMI and
waist-to-hip ratio were associated with age (P  0.0001),
sex (P  0.0001), history of smoking (P  0.0129),
hypertension (P  0.0001), diabetes (P  0.0003), and
hyperlipidemia (P  0.0001). When analyzed with ad-
justment for these variables, a highly signiﬁcant corre-
lation was observed between rs2236302 genotype and
obesity traits (Fig. 4D) (mean  SEM BMI, C/C 22.74 
0.06 vs. C/G 23.16  0.11 kg/m
2; waist-to-hip ratio, C/C
0.901  0.001 vs. C/G 0.906  0.002). The increase of
BMI caused by rs2236302 minor allele was 0.42 kg/m
2
(Cohen d  0.13).
Of note, the positive effect of rs2236302 genotype on
BMI and waist-to-hip ratio was preferentially observed
in women (Fig. 4D), suggesting the existence of sexual
dimorphism in the link between MMP14 and obesity
phenotype (women P  0.0004, d  0.199, vs. men P 
0.5419, d  0.059). Finally, human MMP14 SNPs were
found to be weakly associated with A1C in men (P 
MMP14 LINKS ECM REMODELING AND OBESITY
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of MMP14 SNPs with diabetes predisposition in males.
Consistently, MMP14 haplotype (121) associated with
increased fasting blood glucose (P  0.0069) and HOMA
of insulin resistance (P  0.0386) (Table 3), supporting
a potential link between MMP14 and diabetes in men.
DISCUSSION
In this study, we have demonstrated that a high-fat diet
acutely initiates the MMP14-dependent degradation of the
type I collagen network found in adipose tissues and
induces a selective set of transcripts that link ECM-related
remodeling to lipid/cholesterol biosynthesis. While one
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FIG. 3. MMP14 gene dosage controls nutritional transcriptome response and obesity development. A and B: Disrupted high-fat diet–induced
transcriptome changes in MMP14 haploinsufﬁcient mice. A scatter plot is shown of mRNA expression values (log2 scale) in inguinal fat pads
isolated from MMP14
/ mice fed a control diet (x-axis) vs. high-fat diet (y-axis). In comparison with gene expression proﬁles obtained in
wild-type mice (Fig. 1B), genes involved in a diverse set of metabolic pathways critical to adipose tissue function (asterisks) are misregulated
in MMP14
/ mice. GO, gene ontology. C and D: MMP14 haploinsufﬁciency protects mice from diet-induced increase of fat mass after 3 or 6
months of high-fat diet feeding (means  SD; n  8). Representative images of inguinal and perigonadal fat pads are shown following isolation
from MMP14
/ and MMP14
/ mice that had been placed on high-fat feeding for 3 months. E and F: Feeding bouts (g/day) and metabolic rates
adjusted for lean mass (VO2/kg lean mass) were determined in metabolic cages during high-fat diet feeding. (A high-quality digital representation
of this ﬁgure is available in the online issue.)
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development, our results highlight the quantitative require-
ment of this protease for diet-induced expansion of adi-
pose tissues in vivo. MMP14 gene expression, however, is
not conﬁned to preadipocyte/adipocyte cell population but
can be found in vascular endothelial cells, pericytes, or
ﬁbroblasts (13,29,30). Consequently, MMP14-dependent
remodeling of fat pad architecture may well involve the
cooperative interplay of multiple cell populations. Never-
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FIG. 4. Human MMP14 SNP associations with obesity and diabetes traits in a Japanese cohort. A: Human MMP14 SNPs located in the proximity
of the region encoding MMP14 catalytic domain. Minor allele frequency for each SNP was determined. *SNPs used for haplotype analyses. B:
MMP14 haplotype determinations were based on the combination of rs2236302, rs2236304, and rs2236307. C: Association of human MMP14
haplotypes with BMI. Haplotype associations with BMI of the total population (n  3,531), women (n  1,944), and men (n  1,587) were assessed
in both dominant and recessive inheritance models. The results of ANCOVA analyses are shown with P values. *Any genotype. NS, P value > 0.1.
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panel) are shown for the total population (n  3,647), women (n  1,944), and men (n  1,703), respectively.
TABLE 1
Pairwise Linkage Disequilibrium
Pair of SNPs D
 r
2
rs2236302 and rs2236304 0.977 0.107
rs2236302 and rs2236307 0.993 0.075
rs2236304 and rs2236307 0.995 0.580
D
, linkage disequilibrium measure.
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web with preadipocytes and adipocytes, coupled with the
deposition of collagen degradation products in the peri-
adipocyte space, supports a dominant role for these cells
in diet-induced collagen remodeling. Further, our in vitro
results also support the importance of adipogenic regula-
tion on preadipocyte-mediated collagenolysis. Of note,
human mesenchymal stem cells have recently been shown
to mobilize MMP14 for trafﬁcking and differentiation in
three-dimensional collagen environments (31). Given that
adipocyte progenitors can reside in perivascular stromal
tissues (32,33), it is intriguing to speculate that MMP14
may likewise support the migration and differentiation of
adipocyte progenitors within adipose tissues.
In addition to the ability of MMP14 to remodel collagen
in a diet-dependent manner, the enzyme’s role in regulat-
ing the high-fat diet–responsive early-onset transcriptome
is notable. High-fat diet challenge rapidly—within a
week—induces a selective set of genes enriched for ECM
remodeling and lipid/cholesterol biosynthesis, including
the previously described genes, MEST and Npr3 (34). By
contrast, the enrichment of genes associated with ECM
remodeling and lipid/cholesterol biosynthesis is ablated in
MMP14 haploinsufﬁcient mice, though induction of MEST
and Npr3 gene expression remains intact (supplemental
Tables 1 and 2). The precise molecular mechanism by
which MMP14 gene selectively regulates the fat pad
transcriptome is unknown; however, MMP14-dependent
collagenolysis may regulate transcriptional programs by
modulating cell shape and tension in collagen-rich micro-
environments (7,20). Despite the marked changes in fat
pad size and function observed in MMP14 haploinsufﬁ-
cient mice, VO2 consumption, food intake, and physical
activity in these mice appear to be comparable with
controls. While white adipose tissues of high-fat diet–
challenged MMP14 haploinsufﬁcient mice are small in size,
the efﬁciency with which they oxidize fat versus carbohy-
drate may have undergone adaptive alterations in the in
vivo setting. Indeed, respiratory ratio (VCO2/VO2), was
relatively lower in MMP14 haploinsufﬁcient mice, which is
consistent with a preferred utilization of fat over carbohy-
drate. While severe lipodystrophy increases the risk of
fatty liver (35), we were unable to detect increased triglyc-
eride accumulation in the livers of MMP14 haploinsufﬁ-
TABLE 2
Association of MMP14 haplotype with obesity/diabetes traits
Dominant Recessive
Haplotype P Haplotype P
BMI 1*2 0.0016 2** 0.0016
1** 0.0016
122 0.0017
12* 0.0017
*22 0.0211
Waist-to-hip ratio 122 0.0079 2** 0.0086
12* 0.0080
1*2 0.0084
1** 0.0086
Leptin NS 222 0.0394
A1C NS NS
Fasting blood glucose 121 0.0113 NS
222 0.0460
Fasting insulin *2* 0.0158 *12 0.0125
12* 0.0335 *1* 0.0158
122 0.0404 212 0.0160
*22 0.0419 21* 0.0200
1** 0.0483 2** 0.0483
2*2 0.0494
HOMA-IR 12* 0.0259 *12 0.0272
122 0.0327 212 0.0322
*2* 0.0343 *1* 0.0343
1** 0.0358 2** 0.0358
1*2 0.0445 2* 0.0404
121 0.0496
HOMA- *2* 0.0029 *12 0.0026
*22 0.0604 *1* 0.0029
22* 0.0725 212 0.0041
21* 0.0045
2*2 0.0236
NS, P 	 0.1. *Any genotype. HOMA-, HOMA of -cell function;
HOMA-IR, HOMA of insulin resistance.
TABLE 3
Sexual dimorphism in the link between MMP14 and obesity/diabetes traits
Men Women
Dominant Recessive Dominant Recessive
Haplotype P Haplotype P Haplotype P Haplotype P
BMI NS NS 122 0.0002 2** 0.0004
1** 0.0004
*22 0.0008
Waist-to-hip ratio NS 2*2 0.0417 122 0.0009 2** 0.0015
1** 0.0015
*22 0.0037
Leptin 222 0.0369 222 0.0157 *22 0.0630 NS
2*2 0.0365 112 0.0944
A1C 22* 0.0685 NS NS NS
Fasting blood glucose 121 0.0069 NS NS NS
222 0.094
Fasting insulin NS NS *22 0.0361 NS
HOMA-IR 121 0.0386 NS *22 0.0379 NS
HOMA- *2* 0.0075 *12 0.0065 222 0.0253 NS
*1* 0.0075
212 0.0090
*Any genotype. HOMA-, HOMA of -cell function; HOMA-IR, HOMA of insulin resistance; NS, P 	 0.1.
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wild-type and MMP14
/ mice, respectively; n  6).
In parallel with our ﬁndings in a mouse model of
diet-induced obesity, human MMP14 SNPs were found to
be associated with quantitative traits of obesity and dia-
betes in a Japanese population. The link between MMP14
SNPs and obesity or diabetes traits found in this study may
well be due to altered MMP14 gene expression, catalytic
activity, exocytosis (36), or unknown effects on neighbor-
ing genes that are in linkage disequilibrium. Interestingly,
however, a rare nonsynonymous polymorphism identiﬁed
in exon 5 of MMP14 appears to alter collagenolytic activity
and adipogenic potential in vitro (T.-H.C., unpublished
observations), supporting its potential link with MMP14
catalytic activity. A sib-pair linkage analysis of black and
Caucasian nuclear family volunteers (364 sib pairs) has
pointed to chromosome 14q11, where MMP14 resides, as
one of three candidate loci linked with BMI and fat mass
(37). While genetic risks for obesity have recently been
highlighted by the identiﬁcation of FTO (38) and MC4R
(39) gene variants by genome-wide association studies
(GWAS), candidate-gene approaches are still needed to
bridge the gaps that remain unﬁlled by GWAS analysis
alone (40–42). Our study of a Japanese cohort is of
moderate size (n  3,653) but demonstrates a signiﬁcant
increase of BMI with rs2236302 heterozygosity. The effect
size of this risk allele is modest (BMI 0.42 kg/m
2), which
may not allow for its detection by GWAS. Though multiple
genes affect obesity traits in mice without relevant ﬁndings
in humans, MMP14 gene dose or polymorphism may
deﬁne a genetic susceptibility for obesity traits that spans
the gulf between mice and humans.
In humans, obesity and diabetes phenotypes of MMP14
gene variants display a sexual dimorphism. The stronger
association of MMP14 genotype/haplotypes with obesity
traits in women may relate their higher subcutaneous fat
volume (43). Because subcutaneous fat depots contain
higher concentrations of collagen ﬁbers relative to other
tissues, MMP14-dependent collagenolysis may contribute
more to the size regulation of subcutaneous fat pads in
women. Female mice in the C57BL/6 background, whether
MMP14 wild-type or haploinsufﬁcient, did not signiﬁcantly
change their fat mass in response to diet. However, unlike
male mice, MMP14 haploinsufﬁcient female mice dis-
played a 
30% reduction of fat mass even under the
conditions of a control diet (mean  SD 13.3  1.9 vs.
9.5  0.9% for MMP14
/ and MMP14
/ mice, respec-
tively; n  6). Of note, basal fat mass of female mice is
more than two times higher than that of male mice. As
such, MMP14 might be fully engaged in maintaining adi-
pose tissue mass in female mice—and perhaps in women
as well. Under these conditions, MMP14 gene variants may
be expected to demonstrate an increased linkage with
obesity traits. Additionally, the association of rs2236302
with BMI found in women was reproduced in postmeno-
pausal women (n  1,503, P  0.0008), suggesting that
constitutional but not hormonal differences contribute to
the sexual dimorphism. Conversely, in men, MMP14 gene
variants are associated with diabetes but not obesity traits
(Table 3). The genetic or epigenetic predisposition that
determines obesity or diabetes phenotypes in men, there-
fore, may differentially interact with MMP14 gene variants.
Given the diverse biological functions of MMP family
members interacting with an array of substrates (44), it is
often difﬁcult to pin down the causal relationship between
a speciﬁc MMP and a selective substrate. For example,
MMP3 gene expression and variations are associated with
body fat in Pima Indian population (45). While MMP3 gene
expression decreases in obesity, MMP3 has been shown to
be necessary for adipocyte differentiation in a manner
independent of ECM context (46). Indeed, MMP3 is not
required for type I collagen hydrolysis (47), and the
substrate targets for MMP3 that regulates adiposity are
unknown. By contrast, MMP14-dependent regulation of
adipocyte differentiation is restricted to collagenous mi-
croenvironments (7), suggesting that the MMP14–type I
collagen axis is the dominant pathway operative in adipo-
cytes in vitro as well as in mouse and human adipose
tissues. However, additional interactions with other
MMP14 substrates, or the involvement of additional MMP
family members in this process, cannot be ruled out.
Indeed, MMP13 and MMP2, whose latent forms can be
activated by MMP14 (10,48), may play cooperative roles in
regulating adipocyte function. Additional studies will be
required to identify other pathogenic links that may exist
between MMP family members and their respective sub-
strates during obesity progression. Along these lines, the
metabolic impact of undigested collagen in MMP14
wild-type and haploinsufﬁcient male mice also bears con-
sideration. For example, the transgenic expression of
hypoxia-inducible factor-1 leads to increased ﬁbrosis,
inﬂammatory response, and insulin resistance (49). Hence,
while targeting MMP14 in adipose tissue may prevent
diet-induced fat expansion, the overall impact of reduced
collagen remodeling on inﬂammation and metabolism
remains to be determined. Nonetheless, our data lend
further support to a model wherein MMP14 functions as a
metabolic rheostat that controls the rate of collagen
turnover in adipose tissues. Our in vitro and mouse
studies, combined with SNP association analyses, point to
a critical role for the MMP14/type I collagen axis in
regulating adipose tissue mass in states of nutritional
challenge.
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